IFN-α–Induced Apoptosis in Hepatocellular Carcinoma Involves Promyelocytic Leukemia Protein and TRAIL Independently of p53
Open Access
- 29 January 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (3), 855-862
- https://doi.org/10.1158/0008-5472.can-08-2831
Abstract
IFNs are pleiotropic cytokines that have been shown to be important regulators of cell growth. IFN-α has recently been recognized to harbor therapeutic potential in prevention and treatment of hepatocellular carcinoma (HCC). However, HCC cells respond differentially to IFN treatment, the mechanism of which is largely unknown. To address this issue, we analyzed the effect of IFN-α on different liver tumor cell lines. We found that growth inhibiting effects of IFN-α in hepatoma cells require PML-NB induction and, moreover, tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) expression on the mRNA and protein level. RNAi silencing of PML down-regulates TRAIL expression in hepatoma cells and correspondingly blocks IFN-α–induced apoptosis. In addition, PML-deficient primary hepatocytes fail to up-regulate TRAIL upon IFN-α-treatment in contrast to their wild-type counterparts. These data identify TRAIL as a novel downstream transcriptional target of PML-mediated apoptosis in hepatomas and suggest that PML and TRAIL play important roles in IFN-regulated apoptosis in HCC. Furthermore, the mechanism is independent of the p53 status of the tumor cells. In summary, our results identify central molecules mediating IFN-α induced apoptosis in liver tumors, shed light on the differential response of hepatoma cells to IFN exposure and, thus, may contribute to an efficient application of this substance in the treatment of liver cancer. [Cancer Res 2009;69(3):855–62]This publication has 38 references indexed in Scilit:
- Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-α for advanced hepatocellular carcinoma with extrahepatic metastasisCancer, 2008
- Interferon-α Induces TRAIL Expression and Cell Death Via an IRF-1-Dependent Mechanism in Human Bladder Cancer CellsCancer Biology & Therapy, 2007
- STAT5 Contributes to Interferon Resistance of Melanoma CellsCurrent Biology, 2005
- Transforming growth factor β can mediate apoptosis via the expression of TRAIL in human hepatoma cellsHepatology, 2005
- PML mediates IFN-α–induced apoptosis in myeloma by regulating TRAIL inductionBlood, 2005
- Body language: the function of PML nuclear bodies in apoptosis regulationCell Death & Differentiation, 2003
- Primary human hepatocytes – a valuable tool for investigation of apoptosis and hepatitis B virus infectionJournal of Hepatology, 2003
- Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptorsOncogene, 2002
- Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumorZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Development and mechanisms of interferon resistanceCancer Treatment Reviews, 1990